Physician profile
Jon G Sabol
NPI 1780642132
$2,564.19
in general payments reported to CMS, 2019-2025
6 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $24.49 · 2021: $446 · 2022: $321 · 2023: $13.06 · 2024: $15.47 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290 · Gift: $45.93 · Entertainment: $38.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.54 |
| Gift | $45.93 |
| Entertainment | $38.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $1,820.07 | 2019-2022 | |
| Straumann USA LLC | $440.60 | 2019-2025 | |
| Keystone Dental INC. | $203.23 | 2025 | |
| Salvin Dental Specialties, INC. | $38.89 | 2021 | |
| Dentsply Sirona INC | $32.53 | 2019 | |
| Dentsply Ih INC. | $28.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Sabol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.